Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.
Moja L, Lucenteforte E, Kwag KH, Bertele V, Campomori A, Chakravarthy U, D'Amico R, Dickersin K, Kodjikian L, Lindsley K, Loke Y, Maguire M, Martin DF, Mugelli A, Mühlbauer B, Püntmann I, Reeves B, Rogers C, Schmucker C, Subramanian ML, Virgili G.
Moja L, et al. Among authors: mugelli a.
Cochrane Database Syst Rev. 2014 Sep 15;9(9):CD011230. doi: 10.1002/14651858.CD011230.pub2.
Cochrane Database Syst Rev. 2014.
PMID: 25220133
Free PMC article.
Review.